aod9604 research AOD-9604 (10mg vials) AOD9604 - Oath Research

Administration Instructions Intramuscular Injection Instructions Subcutaneous Injection Instructions 503A vs 503B 503A pharmacies compound products for specific patients whose prescriptions are sent by their healthcare provider

AOD-9604 is a 16-amino-acid peptide engineered as a modified fragment of human growth hormone

These projections assume consistent daily dosing at 300-500 mcg subcutaneous, caloric deficit of 300-500 calories per day, and regular physical activity

weekly, biweekly, or monthly injections are common depending on deficiency and goals

Following your initial treatment period, you might need to receive the shots once a month for three months, and then reduce it to once every three months